Profile
Omer Siddiqui worked as Vice President of Clinical Operations at Allakos, Inc. from 2016 to 2017.
He then worked as Vice President and Head of Development Operations at Alector, Inc. After that, he worked as VP of Development Operations and Project Management at Harpoon Therapeutics, Inc. from 2020 to 2022.
Siddiqui completed his undergraduate degree at the University of Western Ontario.
Former positions of Omer Siddiqui
| Companies | Position | End |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Corporate Officer/Principal | 2022-05-31 |
| ALLAKOS INC. | Corporate Officer/Principal | 2017-05-31 |
| ALECTOR, INC. | Corporate Officer/Principal | - |
Training of Omer Siddiqui
| University of Western Ontario | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ALLAKOS INC. | Health Technology |
| ALECTOR, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Omer Siddiqui
